In transgenic AD mice overexpressing ACE in myelomonocytic cells, enhanced Aβ clearance, a reduced plaque burden, attenuated astrogliosis, and preserved cognitive function were demonstrated, driven by macrophage-mediated phagocytosis. The gene discussed is ACE; the disease is Alzheimer disease.